{"database": "lobbying", "table": "lobbying_activities", "rows": [[1912612, "1cfb61dc-a8c4-47c5-8a88-336e262bd254", "Q4", "ROCK & ASSOCIATES", 33545, "WOMEN'S INTERNATIONAL PHARMACY", 2016, "fourth_quarter", "LAW", "Proposals to amend the Controlled Substances Act to clarify the definition of \"dispense\" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice.  No specific legislation yet.", "HOUSE OF REPRESENTATIVES,SENATE", 11250, null, 0, 0, "2017-01-13T12:27:24-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1912612"], "units": {}, "query_ms": 0.4102680832147598, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}